Profound Medical Corp's stock dropped nearly 4% in the latest trading session, raising concerns among investors.
Profound Medical Corp (PRN.TO) saw a significant decline, closing down 3.97% at CA$8.95. This downturn comes as investor skepticism grows, particularly highlighted by recent commentary from Grow Funds. They pointed out that while the company has potential, other AI stocks might offer more appealing opportunities.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$348.84M
52W high
$12.40
52W low
$5.23
1W change
-5.51%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 160.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+160.7% Upside
Current Price
C$9.60
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
40.5%
Annualized
90-Day Vol
57.4%
Annualized
Trend (90d)
+11.5%
Annualized drift
90d Mean
C$10.00
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$9.73 | C$8.46 โ C$11.19 |
| 60 trading days | C$9.87 | C$8.10 โ C$12.03 |
| 90 trading days | C$10.00 | C$7.85 โ C$12.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious about Profound Medical Corp as it navigates a tough market, especially with competition and investor sentiment shifting towards other tech stocks.
Profound Medical Corp down 3.97% in one day
The stock's decline reflects broader investor concerns, with only 6 hedge funds holding shares compared to 10 in the previous quarter.
Bull case
Profound Medical Corp's innovative TULSA-PRO technology is making waves in the medical device sector. The company has installed a growing number of systems in hospitals and has a solid pipeline for future growth.
Bear case
Recent commentary suggests that Profound Medical Corp may not be the best investment choice compared to other AI stocks. This indicates potential challenges in gaining traction in a competitive market.
Market Performance Overview
In the latest trading session, Profound Medical Corp's stock fell by 3.97%, closing at CA$8.95. This decline is notable as it reflects ongoing investor concerns about the company's growth prospects amidst increasing competition in the medical technology sector.
Investor Sentiment and Hedge Fund Activity
Recent commentary from Grow Funds highlighted a shift in investor sentiment, with only 6 hedge funds holding shares of Profound Medical Corp as of the end of Q1 2026, down from 10 in the previous quarter. This decline in hedge fund interest may signal broader market skepticism regarding the company's future performance.
Competitive Landscape and Future Outlook
Profound Medical Corp's TULSA-PRO technology offers innovative solutions in the medical field, but the company faces stiff competition from other AI-driven medical technologies. Investors should weigh the potential of Profound's offerings against the backdrop of a rapidly evolving market landscape.
Advertisement
